Integral Diagnostics | IDX - 销售收入



金融业
股票价格
AUD 2.11
资产
AUD 744.28M
现金及等价物
AUD 17.99M
销售成本
AUD 11.53M
流动资产
AUD 74.82M
流动负债
AUD 85.68M
债务
AUD 357.8M
股息收益率
3.26
EBIT
AUD 25M
EBITDA
AUD 46.27M
EPS每股收益
AUD 0.04
股本和储备
AUD 301.71M
销售毛利
AUD 226.91M
债务利息支出
AUD 5.34M
利息收入
AUD 482K
贷款资金
AUD 341.63M
市值
AUD 492.52M
净收入
AUD 6.06M
营业费用
AUD 219.16M
营业利润
AUD 19.28M
普通股股本
AUD 335.09M
PE价格收益
17.94
税前利润
AUD 14.49M
销售收入
AUD 238.44M
销售和管理费用
AUD 169.98M
股票
AUD 1.85M
贸易债权人
AUD 28.28M
应收帐款人
AUD 24.82M


销售 更改 日
Alcidion AUD 25.47M 2.32M 2025-12
Ansell USD 1.03B 192.2M 2025-12
Cochlear AUD 1.18B 590.35M 2025-12
CSL USD 8.33B 4.79B 2025-12
Healius AUD 688.1M 245.8M 2025-12
Mayne Pharma AUD 86.5M 125.57M 2026-06
Monash IVF AUD 137.86M 72.09M 2025-12
Nanosonics AUD 102.23M 2.8M 2025-12
Polynovo AUD 79.52M 9.19M 2026-06
Ramsay Health Care AUD 9.24B 100M 2026-12
ResMed USD 1.43B 8.6M 2026-03
Sigma Healthcare AUD 1.68B 188.65M 2024-12
Sonic Healthcare AUD 5.42B 30M 2026-06
Telix Pharmaceuticals AUD 477.35M 63.92M 2026-06